Page last updated: 2024-08-22

camptothecin and eriocalyxin b

camptothecin has been researched along with eriocalyxin b in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fung, KP; Han, Q; Lau, CB; Leung, PC; Leung, PS; Li, L; Sun, H; Yue, GG	1

Other Studies

1 other study(ies) available for camptothecin and eriocalyxin b

Article	Year
Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways. Toxicology and applied pharmacology, 2012, Jul-01, Volume: 262, Issue:1 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Caspases; Cell Line; Cell Line, Tumor; Diterpenes; G2 Phase Cell Cycle Checkpoints; Humans; Liver; M Phase Cell Cycle Checkpoints; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2012

Article

Year

Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways.

Toxicology and applied pharmacology, 2012, Jul-01, Volume: 262, Issue:1

Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Caspases; Cell Line; Cell Line, Tumor; Diterpenes; G2 Phase Cell Cycle Checkpoints; Humans; Liver; M Phase Cell Cycle Checkpoints; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2012